Gerade im Technologiesektor wurde in den vergangenen Wochen alles gnadenlos verkauft, darunter auch gut aufgestellte Unternehmen mit hervorragenden Aussichten für die Zukunft. Welche Titel werden hier aus technischer Sicht langsam wieder interessant? Zwei Werte mit mittelfristigen Erholungschancen. Zur Rose Die Anteilsscheine der Schweizer Onlineapotheke (Doc Morris) korrigierten in den vergangenen Monaten die komplette Rally aus…
| Cookie | Dauer | Beschreibung |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
